Assessment of volume status and arterial stiffness in chronic kidney disease

Renal Failure

Volumn 36, Issue 1, 2014, Pages 28-34

  Akdam, Hakan ^a   Öǧünç, Handan ^b   Alp, Alper ^a   Özbek, Özgül ^a   Ömürlü, Imran Kurt ^a   Yeniçerioǧlu, Yavuz ^a   Akar, Harun ^c  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b Ordu State Hospital   (Turkey)

^c Tepecik Training and Research Hospital ^*  (Turkey)

Author keywords

Arterial stiffness; Augmentation index; Chronic kidney disease; Overhydration; Pulse wave velocity

Indexed keywords

ADULT; AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BIOIMPEDANCE SPECTROSCOPY; BLOOD PRESSURE CUFF; BLOOD VESSEL PARAMETERS; BODY MASS; CENTRAL SYSTOLIC BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; ESTIMATED GLOMERULAR FILTRATION RATE; EXTRACELLULAR FLUID; FAT MASS; FEMALE; FUNCTIONAL ASSESSMENT; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULSE WAVE; SPECTROSCOPY; SYSTOLIC BLOOD PRESSURE; VOLUME STATUS;

ADULT; AGED; BODY COMPOSITION; BODY WATER; CASE-CONTROL STUDIES; ELECTRIC IMPEDANCE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84889568163     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.830224     Document Type: Article

References (48)

1. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, Classification and Stratification. Am J Kidney Dis. 2002;39:1-266.
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:112-119.
3. Süleymanlar G, Utas C, Ar?nsoy T, et al. A population-based survey of chronic renal disease in Turkey-the CREDIT study. Nephrol Dial Transplant. 2011;26:1862-1871.
4. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III Final Report). NIH Publication No. 02-5215; 2002:1-284. Available at: http://www.nhlbi.nih.gov/guidelines/ cholesterol/atp3full.pdf Accessed 17 November 2011.
5. Locatelli F, Pozzoni P, Tentori F, del Vecchio L. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant. 2003;18:Vii2-9.
6. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85-97.
7. Sakuragi S, Abhayaratna WP. Arterial stiffness: methods of measurement, physiologic determinants and prediction of cardiovascular outcomes. Int J Cardiol. 2010;138:112-118.
8. Wang X, Keith Jr JC, Struthers AD, Feuerstein GZ. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. Cardiovasc Ther. 2008;26:214-223.
9. Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. QJM. 2002;95:67-74.
10. Shirwany NA, Zou M. Arterial stiffness: a brief review. Acta Pharmacol Sin. 2010;31:1267-1276.
11. Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens. 2003;21:463-472.
12. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103:987-992.
13. Charra B, Chazot C. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol. 2003;93:94-101.
14. Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA. Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol. 2002;13:177-183.
15. Jatoi NA, Mahmud A, Bennett K, Feely J. Assessment of arterial stiffness in hypertension: comparison of oscillometric (Arteriograph), piezoelectronic (Complior) and tonometric (SphygmoCor) techniques. J Hypertens. 2009;27:2186-2191.
16. Horváth IG, Németh A, Lenkey Z, et al. Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens. 2010;28:2068-2075.
17. Baulmann J, Schillings U, Rickert S, et al. A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. J Hypertens. 2008;26: 523-528.
18. McEniery CM, Yasmin, McDonnell B, et al.; Anglo-Cardiff Collaborative Trial Investigators. Central pressure: variability and impact of cardiovascular risk factors the Anglo-Cardiff Collaborative Trial II. Hypertension. 2008;51:1476-1482.
19. Moissl UM, Wabel P, Chamney PW, et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006;27:921-933.
20. Van Biesen W, Williams JD, Covic AC, et al.; EuroBCM Study Group. Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort. PLoS One. 2011;6(2):e17148.
21. Wabel P, Chamney P, Moissl U, Jirka T. Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif. 2009;27:75-80.
22. De Lorenzo A, Andreoli A, Matthie J, Withers P. Predicting body cell mass with bioimpedance by using theoretical methods: a technological review. J Appl Physiol. 1997;82(5):1542-1558.
23. Chamney PW, Wabel P, Moissl UM, et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007;85:80-89.
24. Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in hemodialysis patients. Nephrol Dial Transplant. 2009;24(5):1574-1579.
25. Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens. 2003;21:463-472.
26. Cohen DL, Townsend RR. Central blood pressure and chronic kidney disease progression. Int J Nephrol. 2011;2011:1-7.
27. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525: 263-270.
28. Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar ME, London GM. Wave reflections and cardiac hypertrophy in chronic uremia: influence of body size. Hypertension. 1993;22:876-883.
29. Yasmin, Brown MJ. Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. Q J Med. 1999;92:595-600.
30. Mills CJ, Gabe IT, Gault JH, et al. Pressure-flow relationships and vascular impedance in man. Cardiovasc Res. 1970;4:405-417.
31. Mahmud A, Feely J. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension. J Hum Hypertens. 2000;14: 541-546.
32. Dart AM, Reid CM, McGrath B. Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension. Am J Hypertens. 2001;14:804-810.
33. Chen CH, Ting CT, Lin SJ, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension. 1995;25:1034-1041.
34. Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des. 2009;15:272-289.
35. Takenaka T, Mimura T, Kanno Y, Suzuki H. Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases. Am J Nephrol. 2005;25:417-424.
36. Fantin F, Mattocks A, Bulpitt CJ, Banya W, Rajkumar C. Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing 2007;36:43-48.
37. Nelson MR, Stepanek J, Cevette M, Covalciuc M, Hurst RT, Tajik AJ. Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform? Mayo Clin Proc. 2010;85:460-472.
38. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753-1760.
39. Mourad JJ, Pannier B, Blacher J, et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int. 2001;59(5):1834-1841.
40. Matsuda N, Takei T, Fujiu A, Ogawa T, Nitta K. Arterial stiffness in patients with non-diabetic chronic kidney disease (CKD). J Atheroscler Thromb. 2009;16(1):57-62.
41. Wang MC, Tsai WC, Chen JY, Huang JJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis. 2005;45:494-501.
42. Yang L, Lin Y, Ye C, et al. Effects of peritoneal dialysis and hemodialysis on arterial stiffness compared with predialysis patients. Clin Nephrol. 2011;75:188-194.
43. Shinohara K, Shoji T, Tsujimoto Y, et al. Arterial stiffness in predialysis patients with uremia. Kidney Int. 2004;65(3):936-943.
44. Benetos A, Zervoudaki A, Kearney-Schwartz A, et al. Effects of lean and fat mass on bone mineral density and arterial stiffness in elderly men. Osteoporos Int. 2009;20:1385-1391.
45. Schouten F, Twisk JW, de Boer MR, et al. Increases in central fat mass and decreases in peripheral fat mass are associated with accelerated arterial stiffening in healthy adults: the Amsterdam Growth and Health Longitudinal Study. Am J Clin Nutr. 2011; 94(1):40-48.
46. Demirci MS, Demirci C, Ozdogan O, et al. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial Transplant. 2011;26:1708-1716.
47. Zheng D, Cheng LT, Zhuang Z, Gu Y, Tang LJ, Wang T. Correlation between pulse wave velocity and fluid distribution in hemodialysis patients. Blood Purif. 2009;27(3):248-252.
48. Zhe XW, Tian XK, Chen W, et al. Association between arterial stiffness and peritoneal fluid kinetics. Am J Nephrol. 2008;28: 128-132.